Total Debt
$2.7M
Net Debt
-$220.1M
Design Therapeutics, Inc. currently has $2.7M in total debt. Net debt is -$220.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
DSGN • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.22 | -0.22Net Cash | 0.23 | 1.2% |
| 2025-12-31 | 0.00 | 0.22 | -0.22Net Cash | 0.23 | 0.7% |
| 2025-09-30 | 0.00 | 0.21 | -0.20Net Cash | 0.21 | 0.8% |
| 2025-06-30 | 0.00 | 0.22 | -0.21Net Cash | 0.22 | 0.9% |
| 2025-03-31 | 0.00 | 0.23 | -0.23Net Cash | 0.24 | 0.9% |
| 2024-12-31 | 0.00 | 0.25 | -0.24Net Cash | 0.25 | 0.9% |
| 2024-09-30 | 0.00 | 0.25 | -0.25Net Cash | 0.26 | 1.0% |
| 2024-06-30 | 0.00 | 0.26 | -0.26Net Cash | 0.27 | 1.0% |
| 2024-03-31 | 0.00 | 0.27 | -0.27Net Cash | 0.28 | 1.0% |
| 2023-12-31 | 0.00 | 0.28 | -0.28Net Cash | 0.29 | 1.1% |
| 2023-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.30 | 1.1% |
| 2023-06-30 | 0.00 | 0.30 | -0.30Net Cash | 0.31 | 1.1% |
| 2023-03-31 | 0.00 | 0.32 | -0.31Net Cash | 0.32 | 1.1% |
| 2022-12-31 | 0.00 | 0.33 | -0.33Net Cash | 0.34 | 1.1% |
| 2022-09-30 | 0.00 | 0.34 | -0.34Net Cash | 0.35 | 1.1% |
| 2022-06-30 | 0.00 | 0.36 | -0.36Net Cash | 0.37 | 1.1% |
| 2022-03-31 | 0.00 | 0.37 | -0.37Net Cash | 0.38 | 0.9% |
| 2021-12-31 | 0.00 | 0.38 | -0.38Net Cash | 0.39 | 0.9% |
| 2021-09-30 | 0.00 | 0.39 | -0.39Net Cash | 0.40 | 0.9% |
| 2021-06-30 | 0.00 | 0.40 | -0.40Net Cash | 0.41 | 0.0% |
| 2021-03-31 | 0.00 | 0.41 | -0.41Net Cash | 0.41 | 0.0% |
| 2020-12-31 | 0.00 | 0.04 | -0.04Net Cash | 0.04 | 0.0% |
| 2020-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |